FOLH1 and prostate cancer: HCT-116 LNCaP prostate cancer cells (PSMA+), CaCo-2 colon cancer cells (PSMA−), and human peripheral monocytes and lymphocytes (PSMA−) were in vitro exposed to fluorescent CNT composites.